Hallucinogenic mushrooms may hold the key to treating anxiety, depression in cancer patients

Researchers might be closing in on a far-out approach to treating anxiety and depression in cancer patients. Two new studies released Thursday indicate that just one dose of psilocybin, a substance found only in hallucinogenic mushrooms, could immediately cut anxiety and depression in cancer patients for as long as eight months.
Two separate trials, the results of which were both published in the Journal of Psychopharmacology, found side effects of the drug to be "minimal," and results to be apparent in about "about 80 percent" of patients, The New York Times reported. "In spite of their unique vulnerability and the mood disruption that the illness and contemplation of their death has prompted, these participants have the same kind of experiences, that are deeply meaningful, spiritually significant, and producing enduring positive changes in life and mood and behavior," said Professor Roland Griffiths, who led the study at the Johns Hopkins University School of Medicine.
Psilocybin, along with other hallucinogens, has been classified as a Schedule 1 drug in the U.S. for more than 40 years. Though these studies' findings were hailed as "the most profound to date in the medical use of psilocybin," scientists say much more research must be done.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Can Starmer sell himself as the 'tough on immigration' PM?
Today's Big Question Former human rights lawyer 'now needs to own the change – not just mouth the slogans' to win over a sceptical public
-
UK-India trade deal: how the social security arrangements will work
The Explainer A National Insurance exemption in the UK-India trade deal is causing concern but should British workers worry?
-
Man arrested after 'suspicious' fires at properties linked to Keir Starmer
Speed Read Prime minister thanks emergency services after fire at his former family home in north London
-
Kurdish PKK militia to disband for Turkey talks
speed read The Kurdistan Workers' Party will disarm after four decades of armed conflict with Turkey, putting an end to 'one of the longest insurgencies in the Middle East'
-
US, China agree to lower tariffs for 90 days
speed read US tariffs will fall to 30% from 145%, while China will cut its tax on US imports to 10% from 125%
-
India strikes Pakistan as tensions mount in Kashmir
speed read Pakistan's Prime Minister Shehbaz Sharif called it an 'act of war'
-
Israel approves plan to take over Gaza indefinitely
speed read Benjamin Netanyahu says the country is 'on the eve of a forceful entry'
-
Putin talks nukes as Kyiv slated for US air defenses
speed read 'I hope they will not be required,' Putin said of nuclear weapons on Russian state TV
-
US, Ukraine sign joint minerals deal
speed read The Trump administration signed a deal with Ukraine giving the US access to its mineral wealth
-
What happens if tensions between India and Pakistan boil over?
TODAY'S BIG QUESTION As the two nuclear-armed neighbors rattle their sabers in the wake of a terrorist attack on the contested Kashmir region, experts worry that the worst might be yet to come
-
Israel launches air strike on Beirut suburbs
Speed Read The attack targeting Hezbollah was Israel's third on the Lebanese capital since November's ceasefire